Movement Alert|Aehr Test Systems Rises 11.96% in Regular Trading, Q4 Earnings Beat and Semiconductor Equipment Sector Strength Drive Gains

Market Focus
Jul 21

On July 21, Aehr Test Systems rose 11.96% in regular trading, trading at $91.765/share, with turnover of $81.78 million. The rally was driven by continued momentum from the company's Q4 earnings beat and broad strength across the semiconductor equipment sector.

The company reported Q4 adjusted EPS of $0.11, significantly beating the consensus estimate of -$0.01. Quarterly new bookings reached a record $60.7 million, pushing total backlog above $100 million. Management issued FY2027 revenue guidance of $130-$150 million, representing nearly triple year-over-year growth, with AI data center business expected to comprise 70% of revenue. Analysts subsequently raised target prices to $125, nearly doubling prior levels.

The company has undergone a dramatic business transformation — two years ago over 95% of revenue came from EV silicon carbide testing, while AI accelerator, CPU, and network processor wafer-level burn-in now contributes 71% of annual revenue.

Within the Semiconductor Equipment sector, the overall sector rallied strongly. Among individual stocks, Teradyne up 9.67%, Applied Materials up 7.02%, KLA-Tencor up 4.08%, Lam Research up 3.79%, ASML Holding up 3.62%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10